Cargando…
BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas
BACKGROUND: Sentinel node biopsy (SNB) is an important step in melanoma staging and prognostication. It is commonly performed for patients with intermediate thickness melanomas, based on clinicopathological features. However, only 20–25% of patients eventually demonstrate nodal involvement. The aim...
Autores principales: | Manninen, Atte A., Gardberg, Maria, Juteau, Susanna, Ilmonen, Suvi, Jukonen, Joonas, Andersson, Noora, Carpén, Olli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490950/ https://www.ncbi.nlm.nih.gov/pubmed/31039200 http://dx.doi.org/10.1371/journal.pone.0216043 |
Ejemplares similares
-
Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients
por: Vuoristo, Mikko, et al.
Publicado: (2021) -
The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
por: Klevesath, M B, et al.
Publicado: (2005) -
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
por: Kohtamäki, Laura, et al.
Publicado: (2021) -
FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome
por: Gardberg, Maria, et al.
Publicado: (2016) -
Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma
por: Rodriguez Otero, Juan Carlos, et al.
Publicado: (2019)